Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Kura Oncology (KURA) Assets Average (2023 - 2025)

Kura Oncology (KURA) has disclosed Assets Average for 3 consecutive years, with $693.9 million as the latest value for Q4 2025.

  • On a quarterly basis, Assets Average rose 12.01% to $693.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $693.9 million, a 12.01% increase, with the full-year FY2025 number at $749.3 million, up 23.94% from a year prior.
  • Assets Average was $693.9 million for Q4 2025 at Kura Oncology, up from $665.9 million in the prior quarter.
  • In the past five years, Assets Average ranged from a high of $752.0 million in Q1 2025 to a low of $460.4 million in Q2 2023.
  • A 3-year average of $580.3 million and a median of $534.5 million in 2024 define the central range for Assets Average.
  • Peak YoY movement for Assets Average: increased 2.63% in 2024, then skyrocketed 49.97% in 2025.
  • Kura Oncology's Assets Average stood at $461.4 million in 2023, then surged by 34.28% to $619.5 million in 2024, then increased by 12.01% to $693.9 million in 2025.
  • Per Business Quant, the three most recent readings for KURA's Assets Average are $693.9 million (Q4 2025), $665.9 million (Q3 2025), and $713.1 million (Q2 2025).